Sep
16
Tue
Cancer Educ Seminar: Beyond Pain: Symptom changes in palliative oncology @ Stanford Cancer Center CC 2103-2104
Sep 16 @ 8:00 am – 9:00 am
Cancer Educ Seminar: Beyond Pain: Symptom changes in palliative oncology @ Stanford Cancer Center CC 2103-2104

Presenter: Kavitha Ramchandran, MD, Clinical Assistant Professor of Medicine (GMD/Oncology)

Sep
8
Tue
Cancer Education Seminar: Palliative Sedation: When, How, Who? @ LKSC 209
Sep 8 @ 8:00 am – 9:00 am
Cancer Education Seminar: Palliative Sedation: When, How, Who? @ LKSC 209 | Stanford | California | United States

Presenter: Kavitha Ramchandran, MD, Clinical Assistant Professor of Medicine (Oncology)

Oct
24
Tue
27th Annual Jonathan J. King Lectureship-Communication in Serious Illness: Getting to Yes @ LKSC, Paul Berg Hall
Oct 24 @ 5:30 pm – 6:30 pm
27th Annual Jonathan J. King Lectureship-Communication in Serious Illness: Getting to Yes @ LKSC, Paul Berg Hall | Palo Alto | California | United States

Presenter: James A. Tulsky, MD
Professor of Medicine, Harvard University
Chair, Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute
Chief, Division of Palliative Medicine, Brigham and Women’s Hospital

James A. Tulsky, MD is Chair, Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute, Chief, Division of Palliative Medicine, Brigham and Women’s Hospital, and Professor of Medicine at Harvard Medical School. Dr. Tulsky has a longstanding interest in doctor-patient communication and quality of life in serious illness, and has published widely in these areas. His current research focuses on the evaluation and enhancement of communication between oncologists and patients with advanced cancer, and evaluating the role of palliative care in congestive heart failure. His work has been recognized with the Presidential Early Career Award for Scientists and Engineers (2002), the Award for Research Excellence from the American Academy of Hospice and Palliative Medicine (2006), and the American Cancer Society Pathfinder in Palliative Care award (2014). He is a Founding Director of VitalTalk (www.vitaltalk.org), a non-profit devoted to nurturing healthier connections between clinicians and patients through communication skills teaching.

 

Sep
19
Wed
Medicine Grand Rounds: Palliative Care Always: A Global Learning Platform @ LKSC Berg Hall
Sep 19 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Palliative Care Always: A Global Learning Platform @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Kavitha Ramchandran, MD
Clinical Associate Professor of Oncology

Stanford University

Kavitha Ramchandran, MD, graduated with an undergraduate degree in Human Biology from Stanford University, did medical school and residency training in medicine at University of California, San Francisco and completed her fellowship in Medical Oncology and Palliative Medicine at Northwestern University, Chicago. She joined faculty at Stanford University in 2007. Currently she is a Clinical Assistant Professor of Medicine in the Division of Oncology and Division of General Medical Disciplines.

Dr. Ramchandran is recognized for her contributions as a leader in the integration of palliative and oncology care. Dr. Ramchandran is one of a small number of dual trained faculty who are working to build synergies between the fields of oncology and palliative medicine in the areas of supportive care research, and novel models of care. She now serves as Stanford Cancer Institute’s Transformation Design lead for improving the palliative care experience for patients with a cancer diagnosis. She is also the Medical Director of Palliative Medicine at Stanford Cancer Institute.

In her care of patients Dr. Ramchandran values a deep relationship with the families she cares for. She provides care that is aligned with the patient and family’s personal values with the goal of the best quality of life possible.

Dr. Ramchandran’s research focuses on developing care delivery models that incorporate values (patients, family members, and clinicians), as well as novel means of palliative care education. She also is part of an active thoracic oncology trials group recruiting patients for clinical trials using novel therapeutics.

Dr. Ramchandran currently serves on the Patient and Survivor Care Committee for the American Society of Clinical Oncology and the National Comprehensive Cancer Network Palliative Care task force. She serves as a clinician in thoracic oncology and in palliative medicine at Stanford Cancer Institute.

Apr
10
Wed
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall
Apr 10 @ 8:00 am – 9:00 am
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Fred Appelbaum, MD

Professor of Medical Oncology, University of Washington

Executive Vice President and Deputy Director, External Affairs, Fred Hutchinson Cancer Research Center

Dr. Appelbaum is the executive director of SCCA. His work centers on the biology and treatment of acute myeloid leukemia.

Decades of working with cancer patients teaches you to savor everyday pleasures like the teasing notes of coriander and cumin in a simmering pot of curry or getting to hug your child, and it fortifies his resolve to keep moving cancer care forward. He’s determined to improve screening, enhance treatment and stop cancer from returning.

As a medical student in the early 1970s, Dr. Appelbaum happened upon Dr. E. Donnall Thomas’ initial description of bone-marrow transplantation in a medical journal. The pioneering technique eventually earned Thomas the Nobel Prize and transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 90 percent.

Bone-marrow transplants became the cornerstone of the newly formed Hutchinson Center, and it wasn’t long before Dr. Appelbaum was recruited to join Thomas’ team of medical mavericks in Seattle making historic inroads against blood cancers.

Now, he holds the job that Thomas once held, and he has spent decades building on Thomas’ groundbreaking innovations. Dr. Appelbaum has been an innovator in his own right, refining transplant procedures, conducting clinical trials and caring for patients.

Part of that job is extending the Hutch’s patient research beyond transplants. We’ve expanded our role in the more common solid tumors and have created nontransplant approaches to blood cancers. We’ve made substantial gains in treating prostate, colon, pancreatic, lung, breast and ovarian cancers, but we have a long way to go.